SBIR/STTR Research Award

Cryo-Imaging of Fluorescently Tagged Cells in the Mouse

Award identifier 099642b0a6ae7455dd5cee538e2135623bddf508ab0bab45f9afe0c82a358a56Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$247,635

Program and phase

STTR · Phase I

Award year

2006

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
BIOINVISION INC
Proposal award date
Not reported
Contract end date
Not reported
UEI
DPL8U7UN1435
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Case Western Reserve University researchers and BioInVision, Inc. will develop a cryo-imaging system for 3D imaging of mice. It will serve applications in stem cell regenerative medicine, metastatic cancer, and pathogen/immune system response, among others. By alternately sectioning and imaging, the system will enable one to acquire 3D high-resolution color and fluorescence episcopic images. This system will image cells tagged with GFP, or other reporter genes which create fluorescent proteins. By imaging with high resolution and sensitivity, we will establish a method for identifying single or multiple tagged cells within a mouse. The system should enable identification of stem cells, micro-metastases, bacteria, lymphocytes, neurons, and other specialized tissues. Once cells are identified, cell locations can be mapped relative to the tissue anatomy in the high contrast, 3D color episcopic images. In addition, histological samples can be obtained for further characterization of the cellular microenvironment and stem cell differentiation. There are other potential applications in biological research and in the pharmaceutical industry, including mouse anatomical phenotype identification, drug evaluation, imaging agent evaluation, drug delivery evaluation, study of diseases, etc. Cryo-imaging is unique among all in vivo and microscopic techniques in that it allows micron resolution and information-rich contrast mechanisms over very large 3D fields of view. It will fill the gap between whole animal in vivo imaging and histology, allowing one to image a mouse along the continuum from the mouse -> organ -> tissue structure -> cell -> sub-cellular domains. We will develope an imaging system that lies within the continuum between in vivo small animal imaging and histology. This sytem will enable researchers to study in great detail where fluoresently tagged cells go in the body, how they change, and how they respond to their microenvironment. This will aid research in stem cell therapy, nerve cell development, immune response, and metastatic cancer, among others. This system will help researchers understand physiology and disease mechanisms and promote research for cures.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

10 SBIR/STTR records share this UEI (2006–2025). Reported award amounts total $7,385,881. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.